findmyKOL
Clinical trialNCT00591734CompletedPhase 2Interventional

RAD001 Plus Bevacizumab in Metastatic Melanoma

SponsorSCRI Development Innovations, LLCEnrollment57Metastatic Melanoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Florida Cancer Specialists

    Fort Myers, Florida, United States

  • Watson Clinic Center for Cancer Care and Research

    Lakeland, Florida, United States

  • Florida Hospital Cancer Institute

    Orlando, Florida, United States

  • Gulfcoast Oncology Associates

    St. Petersburg, Florida, United States

  • Northeast Georgia Medical Center

    Gainesville, Georgia, United States

  • Oncology Hematology Associates of Sw Indiana

    Evansville, Indiana, United States

  • Center for Cancer and Blood Disorders

    Bethesda, Maryland, United States

  • Grand Rapids Clinical Oncology Program

    Grand Rapids, Michigan, United States

  • St. Louis Cancer Care

    Chesterfield, Missouri, United States

  • Methodist Cancer Center

    Omaha, Nebraska, United States

  • Consultants in Medical Oncology and Hematology

    Drexel Hill, Pennsylvania, United States

  • Chattanooga Oncology & Hematology Associates

    Chattanooga, Tennessee, United States

  • Tennessee Oncology, Pllc

    Nashville, Tennessee, United States

  • South Texas Oncology and Hematology

    San Antonio, Texas, United States

  • Virginia Cancer Institute

    Richmond, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2008
Primary completion
31 Oct 2010
Completion
31 Oct 2011
Last update posted
24 Nov 2021
Registered enrollment
57
Registry id
NCT00591734

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.